Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $3.06 in the prior trading day, Braskem S.A. ADR (NYSE: BAK) closed at $3.18, up 3.92%. In other words, the price has increased by $3.92 from its previous closing price. On the day, 1.11 million shares were traded. BAK stock price reached its highest trading level at $3.24 during the session, while it also had its lowest trading level at $3.11.
Ratios:
Our goal is to gain a better understanding of BAK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.76 and its Current Ratio is at 1.32.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 1411923200 and an Enterprise Value of 58827456512. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.04. Its current Enterprise Value per Revenue stands at 0.745 whereas that against EBITDA is 20.692.
Stock Price History:
The Beta on a monthly basis for BAK is 1.70, which has changed by -0.49683547 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, BAK has reached a high of $7.71, while it has fallen to a 52-week low of $2.85. The 50-Day Moving Average of the stock is -10.79%, while the 200-Day Moving Average is calculated to be -26.91%.
Shares Statistics:
The stock has traded on average 978.11K shares per day over the past 3-months and 1601220 shares per day over the last 10 days, according to various share statistics. A total of 172.53M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of 1751241600 were 2857652 with a Short Ratio of 2.92, compared to 1748563200 on 2710929. Therefore, it implies a Short% of Shares Outstanding of 2857652 and a Short% of Float of 3.01.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0.72 and $0.72 for the fiscal current year, implying an average EPS of $0.72. EPS for the following year is -$0.37, with 1.0 analysts recommending between -$0.37 and -$0.37.
Revenue Estimates
3 analysts predict $18.76B in revenue for the current quarter. It ranges from a high estimate of $18.97B to a low estimate of $18.44B. As of the current estimate, Braskem S.A. ADR’s year-ago sales were $19.07BFor the next quarter, 3 analysts are estimating revenue of $20.04B. There is a high estimate of $20.32B for the next quarter, whereas the lowest estimate is $19.8B.
A total of 9 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $84.83B, while the lowest revenue estimate was $73.12B, resulting in an average revenue estimate of $79.46B. In the same quarter a year ago, actual revenue was $77.41BBased on 10 analysts’ estimates, the company’s revenue will be $88.72B in the next fiscal year. The high estimate is $101.05B and the low estimate is $79.1B.
